Tag Archives: PhRMA

After Delays, Project DataSphere Rolls Out

An industry and academic data-sharing project went live on Tuesday, nearly a year after the platform was expected to launch. Visitors to the site – no credentials needed – can register and access de-identified clinical data from the comparator arms of nine oncology trials, with more to come. Project DataSphere, the newest data transparency and […]
Posted in Biotech, Corporate Responsibility, Europe, FDA, Global, IP, leadership, Legal, R&D, Strategy, Technology | Also tagged , , , , , , , , | Leave a comment

180 Diabetes Medicines in Development in the U.S.

America’s biopharmaceutical research companies are currently developing 180 new medicines to help the nearly 400 million people who have diabetes worldwide. These medicines in development, all either in clinical trials or under review by FDA, include 30 for type 1 diabetes, 100 for type 2, and 52 for diabetes-related conditions, according to a new report […]
Posted in R&D | Also tagged , | Leave a comment

Typhoon Trauma: The Pharma Score on Disaster Relief

Big Pharma is quietly stepping up to provide critical supplies of essential medicines, other health equipment, and skilled local personnel to areas of the Philippines devastated by Typhoon Haiyan this month.  Although industry operations in the Philippines appear largely intact, most companies are working through global humanitarian aid organizations due to the logistical challenges created […]
Posted in Corporate Responsibility, Emerging Markets, Global | Also tagged , , , , , , | Leave a comment

Pharma's Transparency Troubles

Transparency Troubles for Pharma High prices, murky financial relations, and a reluctance to disclose clinical data are undermining public trust in industry and the research enterprise, writes Jill Wechsler It seems like open season on the pharmaceutical industry. Academics and consumer activists charge pharma companies with hiding clinical trial information on medical product safety, fueling […]
Posted in Europe, FDA, Guest Blog, Op-Ed, Regulatory | Also tagged , , , , | Leave a comment

PhRMA Research and Hope Awards Gives Industry a Shot in the Arm

Vaccines–once the neglected also ran in big Pharma’s armamentarium of innovations–received top billing at PhRMA’s annual Research and Hope awards held at the Washington Newseum on September 11.  More than 200 industry executives, politicians and scientists recognized the accomplishments of three separate teams in developing and building access to  preventive vaccines.
Posted in Events, healthcare, R&D | Also tagged , , , , , , , , , , , | Leave a comment
  • Categories

  • Meta